Trimethoprim–sulfamethoxazole (TMP–SMX) is a commonly prescribed antimicrobial agent for a wide variety of infections. It is generally well tolerated in a majority of patients; however, serious ...

Background Sulfamethoxazole and trimethoprim (TMP-SMX) is frequently used for urinary tract infections and Pneumocystis prophylaxis in patients on high dose systemic steroids or cyclophosphamide.

Background The prophylactic use of sulfamethoxazole-trimethoprim (SMX/TMP) can reduce the risk for developing pneumocystis pneumonia in immunosuppressed patients with systemic rheumatic diseases, ...

In Cox-regression analysis, higher baseline serum immunoglobulin M levels were associated with the risk of severe infections, whereby a higher baseline total CD19+B cell number and prophylaxis against ...

Participants and outcomes The RCT included hospitalised patients with documented or highly-probable invasive MRSA infections who were randomised to vancomycin versus trimethoprim-sulfamethoxazole (TMP ...

Background: Guidelines recommend that agents other than vancomycin be considered for some types of infection due to methicillin-resistant Staphylococcus aureus (MRSA) when the minimum inhibitory ...

Sulfamethoxazole 400mg, trimethoprim 80mg; scored tabs. Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid (PABA). Trimethoprim blocks the ...

Sulfamethoxazole 200mg, trimethoprim 40mg; per 5mL; cherry or grape flavor; alcohol 0.26%. Sulfamethoxazole inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic ...

The right thigh was tender to palpation. Given the immunocompromised status of the host, the Gram stain results triggered initiation of oral trimethoprim–sulfamethoxazole (TMP/SMX) to cover the ...